Chemclin Diagnostics Co., Ltd. (SHA:688468)

China · Delayed Price · Currency is CNY

6.61

-0.08 (-1.20%)

Oct 8, 2026, 2:04 PM CST

Chemclin Diagnostics Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	322.53	332.68	436.29	445.34	465.27	470.77
Revenue Growth	-14.07%	-23.75%	-2.03%	-4.28%	-1.17%	12.57%
Gross Profit	195.73	213.58	320.94	334.78	344.16	350.94
Operating Income	17.65	31.14	107.65	131.61	135.11	137.12
Net Income	35.11	43.91	127.07	147.37	152.63	142.76
Earnings Per Share	0.09	0.11	0.32	0.37	0.38	0.37
EPS Growth	-52.12%	-65.63%	-13.51%	-2.63%	2.70%	12.12%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	513.88	615.11	909.25	918.66	985.14	924.63
Total Debt	229.85	231.97	249.76	234.61	12.47	24.6
Net Cash (Debt)	284.03	383.14	659.5	684.05	972.67	900.03
Net Cash Growth	-52.26%	-41.90%	-3.59%	-29.67%	8.07%	62.64%
Net Cash Per Share	0.73	0.96	1.66	1.72	2.42	2.33

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	106.85	93.9	167.95	173.05	244.56	188.86
Capital Expenditures	-33.66	-69.88	-107.49	-301.37	-125.28	-72.55
Free Cash Flow	73.19	24.01	60.46	-128.32	119.28	116.31
Free Cash Flow Growth	43.49%	-60.28%	-	-	2.55%	69.43%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	60.69%	64.20%	73.56%	75.17%	73.97%	74.54%
Operating Margin	5.47%	9.36%	24.67%	29.55%	29.04%	29.13%
Pretax Margin	12.54%	14.97%	31.61%	37.30%	38.12%	34.45%
Profit Margin	10.88%	13.20%	29.13%	33.09%	32.80%	30.32%
FCF Margin	22.69%	7.22%	13.86%	-28.81%	25.64%	24.71%

Dividends

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.125	0.125	0.347	0.170
Dividend Per Share Growth	0%	-63.98%	104.12%	-
Dividend Yield	1.86%	1.20%	3.91%	1.03%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	74.43	65.96	21.27	29.36	24.88	50.34
P/FCF Ratio	36.07	120.62	44.71	-	31.84	61.78
PS Ratio	8.18	8.71	6.20	9.72	8.16	15.26